Vivesto
0.09 SEK
+0.53 %
Less than 1K followers
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+0.53 %
-19.23 %
-22.56 %
-51.11 %
-53.30 %
-51.11 %
-73.08 %
-96.73 %
-99.40 %
Vivesto is a pharmaceutical company focused on developing innovative treatments for serious oncology diseases. The company is researching new therapies that can improve patient outcomes and quality of life. The company operates globally with a primary presence in Europe and North America. Vivesto was founded in 1988 and is headquartered in Uppsala, Sweden.
Read moreMarket cap
105.07M SEK
Turnover
16.82K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27/2
2026
Annual report '25
7/5
2026
General meeting '26
7/5
2026
Interim report Q1'26
All
Webcasts
Press releases
3rd party
ShowingAll content types
Vivesto carries out a directed share issue to guarantors in connection with the completed rights issue
Finansinspektionen: Flaggningsmeddelande i Vivesto AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools